ArticleAACE endocrinology and diabetes
Primary Adrenal Insufficiency Due to Recurrent Unilateral Adrenal Infarction in a Patient With Myelodysplastic Syndrome With Isolated del(5q).
Article in AACE endocrinology and diabetes. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background/Objective: Adrenal infarction is a rare cause of primary adrenal insufficiency (PAI), typically associated with hypercoagulable states. While PAI usually results from simultaneous bilateral adrenal involvement, progression from unilateral infarction to bilateral disease leading to PAI is rare. We report the first documented case of adrenal infarction in a patient with myelodysplastic syndrome (MDS) with isolated del(5q), who presented with recurrent unilateral adrenal infarction leading to bilateral involvement and PAI. Case description: A 72-year-old woman with thrombocythemia secondary to MDS with isolated del(5q) on cilostazol therapy presented with left-sided lumbago. Imaging studies, including computed tomography and magnetic resonance imaging, revealed left adrenal infarction. A cosyntropin stimulation test revealed a normal cortisol response. Two months later, the patient developed a second infarction in the right adrenal gland. The patient was diagnosed with PAI confirmed by a low cortisol response to cosyntropin, and started glucocorticoid replacement. Four months later, the patient had a third infarction in the left adrenal gland. Intensifying prophylactic antithrombotic therapy for recurrent adrenal infarction was not considered necessary, as the clinical management would remain unchanged: glucocorticoid replacement for PAI is required regardless of recurrence. Conclusion: We present the first case of recurrent unilateral adrenal infarctions associated with MDS with isolated del(5q), which progressively led to bilateral involvement and PAI. This case suggests the importance of assessing adrenal function and individualized consideration of prophylactic antithrombotic therapy in patients with adrenal infarction.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.